A new study from the medical division of Canopy Growth Corp., Spectrum Therapeutics, has found that long-term CBD consumption could provide some benefits later in life, at least in worms.
The study, which was undertaken with Caenorhabditis elegans (C. elegans) worms, attempted to shed light on the potential long-term impacts of CBD use.
Using the worm models, researchers found that CBD “did not demonstrate any degree of acute or life-long toxicity or related liabilities at physiological concentrations.”
Instead, researchers saw that worms treated with CBD saw their lifespan increase by almost 20 per cent and their “late-stage life activity” increase by more than 200 per cent.
“These results serve as the only CBD life-long exposure data in an in vivo model to date, and the absence of long-term toxicity gives us the evidence we need as an industry to continue researching the potential health benefits for the broader application of CBD,” Hunter Land, a senior director at Canopy Growth, says in a statement.
The worm models were selected as C. elegansshare 60 to 80 per cent of their genes with humans and have a lifespan of just a few weeks.